LifeMD: Still My Favorite Bargain On The Market

2026-02-26 02:21:25 ET

Back in September 2025, I wrote an article on LifeMD ( LFMD ) and assigned my first ever Strong Buy rating. I saw LifeMD as an underappreciated telehealth company with a similar business model to Hims & Hers Health ( HIMS ) but at a much cheaper price. At the time of writing that article, LifeMD had already seen a huge price correction, and in my eyes, it was cheap after having come back down to earth from optimistic assumptions (the stock peaked at $15 in the earlier part of 2025)....

Read the full article on Seeking Alpha

For further details see: